期刊文献+

关节病型银屑病患者外周血中血管内皮生长因子(VEGF)水平的动态观测 被引量:4

The Observation of Dynamic State on the Level of the Peripheral Blood Vascular Endothelial Growth Factor in Patients with Psoriasis Arthropathica
暂未订购
导出
摘要 目的:检测关节病型银屑病患者外周血中VEGF水平的改变,探讨其与PASI评分、治疗前后的关系。方法:采用双抗体夹心酶联免疫技术(ELISA)检测23例关节病型银屑病患者治疗前、中、治疗后血清中VEGF水平。另检测了23例正常人血清中的VEGF水平作为对照组。结果:关节病型银屑病患者血清中VEGF水平较正常对照组显著增高(P<0.001),治疗前后患者血清中VEGF水平有显著差异(P<0.05)。结论:VEGF在关节病型银屑病发病机制中起重要作用。 Objective:The changes of serum vascular endothelial growth factor VEGF levels in psoriasis arthropathica were measured, and the relationship among cytokins, PASI and treatment were studied. Methods: Levels of VEGF in sera was measured by double antibody sandwich enzyme- linked immunosorbent assay (ELISA) in patients with psoriasis arthropathica before and after treatment and normal controls. Results: Serum levels of VEGF were significantly increased in patients with psoriasis arthropathica as compared with normal controls ( P 〈 0. 001 ) , and there was significant differenee between two groups of before and after treatment( P 〈 0.05 ). Conclusions: The VEGF may be very important to the pathogenesis of psoriasis arthropathica.
出处 《岭南皮肤性病科杂志》 2005年第3期202-204,共3页 Southern China Journal of Dermato-Venereology
关键词 银屑病 血管内皮生长因子 外周血 关节炎性 Psoriasis Vascular endothelial growth factor Peripheral blood Arthritis
  • 相关文献

参考文献10

  • 1郑敏,浙江大学医学院第二医院皮肤科.银屑病是细胞免疫介导性疾病?[J].中华皮肤科杂志,2002,35(2):85-87. 被引量:90
  • 2张江林,黄烽,刘湘源.银屑病关节炎临床特点及与HLA-B27的相关性研究[J].中华风湿病学杂志,1999,3(2):87-89. 被引量:23
  • 3Fava RA, Olsen NJ, Sppencer G, et al. Vascular perme - ability factor endothelial growth factor ( VPF VEGF):accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med, 1994,180 ( 1 ):341 ~ 346
  • 4Ruzicka T. Psoriatic arthritis: new types, new treatment.Arcdermatol, 1996,132 ( 2 ) :215.
  • 5李世泰 解毓章 蒋明.银屑病性关节炎临床和放射学分析[J].中华皮肤科杂志,1987,20(3):151-151.
  • 6Hareld F, Dvotak, Lawrence F, Brown, et al. Vascular permeability factor, microvascular hypermeability, and angiogenesis. Am J Pathology, 1995, (146) :1029.
  • 7Detmar M, Brown LF, Claffey KP, et al. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med, 1994,180:1141 ~ 1146.
  • 8Bhushan M, Mclaughlin B, Weiss JB, et al. Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis. Br J Dermatol, 1999, 141: 1054~ 1060.
  • 9张锡宝,罗权,吴志华,陈绍谦.血管内皮生长因子及其受体在银屑病发病中的作用及意义[J].中华皮肤科杂志,2005,38(3):140-142. 被引量:30
  • 10Giannelli G, Erriquez R, Iannone F, et al. MMP -2,MMP - 9, TIMP - 1 and TIMP - 2 levels in patients with rheumatoid arthritis and psoriatic arthritis. Clin Exp Rheumatol. 2004,22 (3) :335 ~ 338.

二级参考文献16

  • 1朱凡,郑敏,鲍彰.银屑病患者皮损中血管内皮生长因子受体的表达与血管增生的关系[J].中华皮肤科杂志,2003,36(7):365-367. 被引量:33
  • 2Detmar M, Brown LF, Claffey KP, et al. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med, 1994, 180: 1141-1146.
  • 3Dvorak HF, Brown LF, Detmar M, et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability,and angiogenesis. Am J Pathol, 1995, 146: 1029-1039.
  • 4Weider N. Current pathologic methods for measuring intratumoral microvessel density with breast carcinoma and other solid tumor.Breast Cancer Res Treat, 1995, 36: 169-175.
  • 5Decaussin M, Sartelet H, Robert C, et al. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R-1-Flt1 and VEGF-R-2-Flk1/KDR) in non-small-cell lung carcinomas(NSCLCs): correlation with angiogenesis and survival. J Pathol,1999, 188: 369-377.
  • 6Bhushan M, Mclaughlin B, Weiss JB, et al. Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis. Br J Dermatol, 1999, 141: 1054-1060.
  • 7Kondo S, Yoneta A, Yazawa H, et al. Downregulation of CXCR- 2 but not CXCR- 1 expression by human keratinocytes by UVB. J Cell Physiol, 2000,182:366- 370.
  • 8Vandenbark AA, Morgan E, Bartholomew R, et al. TCR peptide therapy in human autoimmune diseases. Neurochem Res, 2001,26:713- 730.
  • 9Raychaudhuri SP, Farber EM. Neuroimmunologic aspects of psoriasis. Cutis, 2000,66:357- 362.
  • 10Schroder JM, Harder J. Human beta- defensin- 2. Int J Biochem Cell Biol, 1999,31:645- 651.

共引文献139

同被引文献42

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部